BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 32693062)

  • 21. C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells.
    Manzano S; Gutierrez-Uzquiza A; Bragado P; Sequera C; Herranz Ó; Rodrigo-Faus M; Jauregui P; Morgner S; Rubio I; Guerrero C; Porras A
    Cell Death Dis; 2021 Apr; 12(4):348. PubMed ID: 33824275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels.
    Wang C; Tong X; Yang F
    Mol Pharm; 2014 Jul; 11(7):2115-25. PubMed ID: 24712441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TROY signals through JAK1-STAT3 to promote glioblastoma cell migration and resistance.
    Ding Z; Kloss JM; Tuncali S; Tran NL; Loftus JC
    Neoplasia; 2020 Sep; 22(9):352-364. PubMed ID: 32629176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways.
    Ma H; Li T; Tao Z; Hai L; Tong L; Yi L; Abeysekera IR; Liu P; Xie Y; Li J; Yuan F; Zhang C; Yang Y; Ming H; Yu S; Yang X
    J Cell Physiol; 2019 Feb; 234(2):1630-1642. PubMed ID: 30159893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RhoA and RhoC are involved in stromal cell-derived factor-1-induced cell migration by regulating F-actin redistribution and assembly.
    Luo J; Li D; Wei D; Wang X; Wang L; Zeng X
    Mol Cell Biochem; 2017 Dec; 436(1-2):13-21. PubMed ID: 28536953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effects of adenovirus mediated tandem expression of RhoA and RhoC shRNAs in HCT116 cells.
    Liu XP; Wang HB; Yang K; Sui AH; Shi Q; Qu S
    J Exp Clin Cancer Res; 2009 Apr; 28(1):52. PubMed ID: 19374769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Three-dimensional hydrogel is suitable for targeted investigation of amoeboid migration of glioma cells.
    Huang Y; Tong L; Yi L; Zhang C; Hai L; Li T; Yu S; Wang W; Tao Z; Ma H; Liu P; Xie Y; Yang X
    Mol Med Rep; 2018 Jan; 17(1):250-256. PubMed ID: 29115617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ODZ1 allows glioblastoma to sustain invasiveness through a Myc-dependent transcriptional upregulation of RhoA.
    Talamillo A; Grande L; Ruiz-Ontañon P; Velasquez C; Mollinedo P; Torices S; Sanchez-Gomez P; Aznar A; Esparis-Ogando A; Lopez-Lopez C; Lafita C; Berciano MT; Montero JA; Vazquez-Barquero A; Segura V; Villagra NT; Pandiella A; Lafarga M; Leon J; Martinez-Climent JA; Sanz-Moreno V; Fernandez-Luna JL
    Oncogene; 2017 Mar; 36(12):1733-1744. PubMed ID: 27641332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propentofylline inhibits glioblastoma cell invasion and survival by targeting the TROY signaling pathway.
    Dhruv HD; Roos A; Tomboc PJ; Tuncali S; Chavez A; Mathews I; Berens ME; Loftus JC; Tran NL
    J Neurooncol; 2016 Feb; 126(3):397-404. PubMed ID: 26559543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells.
    Bourguignon LY; Gilad E; Brightman A; Diedrich F; Singleton P
    J Biol Chem; 2006 May; 281(20):14026-40. PubMed ID: 16565089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The activation of RhoC in vascular endothelial cells is required for the S1P receptor type 2-induced inhibition of angiogenesis.
    Del Galdo S; Vettel C; Heringdorf DM; Wieland T
    Cell Signal; 2013 Dec; 25(12):2478-84. PubMed ID: 23993968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase.
    Zheng R; Iwase A; Shen R; Goodman OB; Sugimoto N; Takuwa Y; Lerner DJ; Nanus DM
    Oncogene; 2006 Sep; 25(44):5942-52. PubMed ID: 16652149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer.
    Kamai T; Tsujii T; Arai K; Takagi K; Asami H; Ito Y; Oshima H
    Clin Cancer Res; 2003 Jul; 9(7):2632-41. PubMed ID: 12855641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NKCC1 Regulates Migration Ability of Glioblastoma Cells by Modulation of Actin Dynamics and Interacting with Cofilin.
    Schiapparelli P; Guerrero-Cazares H; Magaña-Maldonado R; Hamilla SM; Ganaha S; Goulin Lippi Fernandes E; Huang CH; Aranda-Espinoza H; Devreotes P; Quinones-Hinojosa A
    EBioMedicine; 2017 Jul; 21():94-103. PubMed ID: 28679472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
    Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
    Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying conserved molecular targets required for cell migration of glioblastoma cancer stem cells.
    Volovetz J; Berezovsky AD; Alban T; Chen Y; Lauko A; Aranjuez GF; Burtscher A; Shibuya K; Silver DJ; Peterson J; Manor D; McDonald JA; Lathia JD
    Cell Death Dis; 2020 Feb; 11(2):152. PubMed ID: 32102991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ILK silencing inhibits migration and invasion of more invasive glioblastoma cells by downregulating ROCK1 and Fascin-1.
    Louca M; Zaravinos A; Stylianopoulos T; Gkretsi V
    Mol Cell Biochem; 2020 Aug; 471(1-2):143-153. PubMed ID: 32506247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The semaphorin receptor plexin-B1 signals through a direct interaction with the Rho-specific nucleotide exchange factor, LARG.
    Aurandt J; Vikis HG; Gutkind JS; Ahn N; Guan KL
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12085-90. PubMed ID: 12196628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RND3 promotes Snail 1 protein degradation and inhibits glioblastoma cell migration and invasion.
    Liu B; Dong H; Lin X; Yang X; Yue X; Yang J; Li Y; Wu L; Zhu X; Zhang S; Tian D; Wang J; Cai Q; Mao S; Chen Q; Chang J
    Oncotarget; 2016 Dec; 7(50):82411-82423. PubMed ID: 27705942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular plasticity confers migratory and invasive advantages to a population of glioblastoma-initiating cells that infiltrate peritumoral tissue.
    Ruiz-Ontañon P; Orgaz JL; Aldaz B; Elosegui-Artola A; Martino J; Berciano MT; Montero JA; Grande L; Nogueira L; Diaz-Moralli S; Esparís-Ogando A; Vazquez-Barquero A; Lafarga M; Pandiella A; Cascante M; Segura V; Martinez-Climent JA; Sanz-Moreno V; Fernandez-Luna JL
    Stem Cells; 2013 Jun; 31(6):1075-85. PubMed ID: 23401361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.